ctrl K

Price Alert

Milestone Pharmaceuticals... (MIST)

NASDAQ: MIST · Real-Time Price · USD

1.68

-0.02 (-1.18%)

At close: Aug 19, 2025, 1:54 PM

Milestone Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	25.31M	13.76M	7.64M	114.14M
Short-Term Investments	44.38M	52.24M	56.95M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-2.68M	-926K
Receivables	2.39M	3.85M	1.21M	483K
Inventory	n/a	n/a	-331K	-356K
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	73.93M	73.03M	71.8M	118.92M
Property-Plant & Equipment	1.57M	2.19M	2.68M	926K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.57M	2.19M	2.68M	926K
Total Assets	75.5M	75.23M	74.48M	119.85M
Account Payables	1.93M	3.98M	2.26M	4.38M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	571K	n/a	495K	224K
Other Current Liabilities	3.12M	1.99M	2.08M	1.23M
Total Current Liabilities	8.13M	7.23M	6.14M	6.78M
Long-Term Debt	53.35M	49.77M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	54.23M	51.23M	2M	474K
Total Liabilities	62.35M	58.45M	8.13M	7.25M
Total Debt	54.8M	51.77M	2.49M	698K
Common Stock	288.05M	260.5M	273.9M	251.9M
Retained Earnings	-367.55M	-326.03M	-266.34M	-206.32M
Comprehensive Income	n/a	48.46M	34.35M	-1.63M
Shareholders Equity	13.15M	16.77M	66.35M	112.6M
Total Investments	44.38M	52.24M	56.95M	n/a